Loading market dashboard

Financials in CAD. Standardized financial statements.
A compact view of how Britannia Life Sciences Inc. turns revenue into operating income and net income.
| Metric | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $369,279 | $7.57M | $6.40M | $7.30M | $1.42M | $974,269 | $186,025 | $0 | $0 | $9,146 |
| Revenue Growth? | -95.1% | +18.2% | -12.3% | +412.4% | +46.2% | +423.7% | 0.0% | 0.0% | -100.0% | 0.0% |
| Cost of Revenue? | $341,951 | $2.72M | $1.77M | $2.04M | $253,031 | $688,889 | $352,706 | $43,022 | $19,935 | $147,111 |
| Gross Profit? | $27,328 | $4.85M | $4.64M | $5.26M | $1.17M | $285,380 | -$166,681 | -$43,022 | -$19,935 | -$137,965 |
| Gross Margin? | +7.4% | +64.1% | +72.4% | +72.1% | +82.2% | +29.3% | -89.6% | 0.0% | 0.0% | -1508.5% |
| Operating Expenses? | $2.28M | $4.68M | $4.46M | $4.88M | $1.06M | $5.49M | $5.13M | $1.95M | $557,034 | $1.80M |
| Operating Income? | -$2.25M | $173,000 | $177,744 | $379,567 | $114,828 | -$5.20M | -$5.29M | -$1.99M | -$576,970 | -$1.94M |
| EBITDA? | -$4.39M | -$1.90M | $6.95M | -$10.77M | -$1.62M | -$5.35M | -$11.11M | -$1.99M | -$744,842 | -$2.71M |
| Income Before Tax | -$4.56M | -$4.47M | $5.86M | -$13.27M | $400,638 | -$7.13M | -$11.86M | -$2.39M | -$1.11M | -$3.29M |
| Income Tax Expense | $0 | -$67,355 | $19,864 | $711,592 | $257,662 | $0 | $0 | -$2 | $5 | $0 |
| Net Income? | $7.39M | -$4.77M | $5.08M | -$15.46M | -$157,162 | -$7.13M | -$11.86M | -$2.39M | -$1.11M | -$3.29M |
| EPS? | $-0.03 | $-0.03 | $0.03 | $-0.14 | $-0.00 | $-1.23 | $-2.37 | $-0.91 | $-4.96 | $-18.84 |
| Diluted EPS? | $-0.03 | $-0.03 | $0.03 | $-0.14 | $-0.00 | $-1.23 | $-2.37 | $-0.91 | $-4.96 | $-18.84 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality